SARS-CoV-2: Difference between revisions
From IDWiki
(Created page with "== Background == === Microbiology === * Coronavirus related to SARS-CoV === Epidemiology === * Pandemic in 2020 == Clinical Presentation == * Incubation period 4-5 days...") Â |
(→â€) |
||
| Line 13: | Line 13: | ||
== Management == |
== Management == |
||
* Primarily supportive |
* Primarily supportive |
||
| − | * Investigational therapeutics include [[tocilizumab]], [[ |
+ | * Investigational therapeutics include [[tocilizumab]], [[lopinavir/ritonavir]], and [[chloroquine]] |
[[Category:Viruses]] |
[[Category:Viruses]] |
||
Revision as of 19:46, 14 March 2020
Background
Microbiology
- Coronavirus related to SARS-CoV
Epidemiology
- Pandemic in 2020
Clinical Presentation
- Incubation period 4-5 days on average, possibly as long as 14 days in some cases
- Main presenting symptoms were fever and cough
- Other symptoms include dyspnea, rhinorrhea, vomiting, diarrhea
Management
- Primarily supportive
- Investigational therapeutics include tocilizumab, lopinavir/ritonavir, and chloroquine
References
- ^ Louise Lansbury, Benjamin Lim, Vadsala Baskaran, Wei Shen Lim. Co-infections in people with COVID-19: a systematic review and meta-analysis. Journal of Infection. 2020;81(2):266-275. doi:10.1016/j.jinf.2020.05.046.
